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Sanfujiu is a treatment method of applying herbal paste onto the acupoints Fengmen and Feishu during
the three hottest days of summer to treat patients with allergies. The objectives of this study were to
determine the treatment efficacy at 1 year after the Sanfujiu treatment, and examine variations in the
perceived efficacy of Sanfujiu among different subgroups, based on the patients’ ages, diagnoses and
number of reactive symptoms immediately after the treatment. We enrolled 105 patients who completed
Sanfujiu treatment at a medical university hospital in Taipei as the subjects. One year after treatment,
trained interviewers conducted telephone interviews with the patients. Approximately 60% of them
perceived the treatment as being effective at 1 year later, which was higher than that at 1 week after
treatment (45.7%). Younger subjects (<19 years of age) and patients with asthma were more likely to
report the treatment as being effective. Patients who had more reactive symptoms after the third Sanfujiu
treatment were more likely to report the treatment as being effective. The results demonstrated that
Sanfujiu was moderately effective, as perceived by patients in Taiwan, in treating their allergic
symptoms.
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Introduction
Symptoms associated with allergies are very common in
developing and developed countries alike. The most common
types of allergic symptoms include eczema, rhinitis and
asthma. Allergies have increased substantially during the
past two or three decades in many countries around the
world (1). A study comprised mostly of the Chinese children
aged 6–7 years in Hong Kong showed that lifetime
prevalence of asthma, rhinitis and eczema were 7.9, 33.9 and
30.7% (2). In Taiwan, the prevalence of physician-diagnosed
asthma among elementary and middle school students was
8.1% for boys and 5.6% for girls (3). In a survey of middle-
school students in Taiwan, Lee et al. (4) reported the
prevalence was 25.0–30.1% for physician-diagnosed
allergic rhinitis, and 40.2–43.0% for questionnaire-determined
allergic rhinitis.
According to traditional Chinese medicine (TCM) theory, qi
is part of everything that exists (5). Qi has been described as a
type of metaphysical energy that sustains living beings.
Proponents of TCM assert that natural patterns of qi are
associated with the body that circulates in channels (or
meridians). The environment also has natural patterns of qi
that circulate in natural order, such as sunrise and sunset, and
changes of the four seasons. By adjusting the circulation of qi
inside the body, health of individuals can be improved. There
are two main kinds of qi, yang qi and yin qi. Yang qi moves
like sun with a nature of hotness, whereas yin qi moves like
moon with a nature of coldness. According to TCM theory,
allergies are related to deficiencies in the lungs, which
indicates disorders in the respiratory system. In TCM, patients
with allergies are viewed as being cold and lacking yang qi
inside the body. Traditionally, Sanfujiu is a treatment method
of applying Chinese herbal medicine paste onto the acupoints
Fengmen and Feishu during the three hottest days (or dog
days) of the summer (6). The rationale is that the dog days are
those days with the highest amount of yang qi according to the
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allows the patient to gather qi from the environment, which
enhances the herb’s effect as it penetrates the acupoints,
and strengthens lung qi. This type of treatment is believed
to help prevent allergic attacks during the winter and early
spring months.
Because of the non-invasive and easy-to-administer nature
of the Sanfujiu treatment, Sanfujiu has been increasingly used
in TCM clinics in Taiwan. We previously reported the
immediate reactions (adverse effects and perceived efficacy)
to Sanfujiu treatment at 1 week after treatment (7). In that
study, we reported that reactive symptoms to treatment were
common, but were usually mild. About 45% of patients
perceived treatment as being effective at 1 week later.
However, the actual treatment efficacy of Sanfujiu should be
determined at the end of winter and spring, when allergic
symptoms are the most evident. This study followed the same
group of patients for 1 year after completion of the Sanfujiu
treatment. The objectives were to describe treatment efficacy
at 1 year after Sanfujiu and examine variations in the perceived
efficacy of Sanfujiu among different subgroups based on the
patients’ ages, diagnoses and number of reactive symptoms
immediately after treatment.
Methods
A detailed description of the Sanfujiu treatment can be found
in our previous publication (7). Briefly, Sanfujiu is the
application of an herbal paste onto the acupoints Fengmen
(BL12) and Feishu (BL13) during the three dog days of
summer. Fengmen is located at the level of the lower border of
the spinous process of the second thoracic vertebra. Feishu
locates at the level of the lower border of the spinous process
of the third thoracic vertebra. Using TCM theory, these two
acupoints regulate lung qi, open the lungs and benefit all
aspects of lung function (8). According to the lunar calendar,
the three dog days (peak summer days) are the third and
fourth Geng days after the summer solstice, and the first
Geng day after the beginning of autumn, respectively (6).
In the year 2003, these days corresponded to July 16, July 26
and August 15. The herbal paste was composed of
equal amounts of dried Bai Jie Zi (Semen Sinapis Albae),
dried Xi Xin (Herba Asari), dried Gan Sui (Radix Kansui),
dried Yan Hu Suo (Rhizoma Cordalis) and fresh ginger
(Zingiber officinale). Except for the ginger, the four
dried herbs were ground into a powder. The ginger was
blended into a juice. Then the powder and juice were mixed
and made into a paste. All of the five herbs except for the
ginger were imported from Mainland China. The ginger was
obtained locally in Taipei, Taiwan. One licensed pharmacol-
ogist and one doctor in Chinese Medicine checked the crude
herbs. Unlike concentrated extracted medicine, the crude herbs
are not seen or labeled as products of a company and there
is no quality control policy toward the crude herbs. The
herbal paste was divided into small cubes of 3 g each
and placed on the Fengmen (BL12) and Feishu (BL13),
bilaterally (a total of four acupoints). Medical tape was used
to keep the medicinal paste in place on the acupoints for 2 h
(see Fig. 1).
Subjects
In 2003, 119 patients completed the Sanfujiu treatment at a
medical university hospital in Taipei. The inclusion criteria
were patients who had undergone this treatment and had been
diagnosed with allergies by a medical doctor based on the
patients’ reports. Of the 119 patients, 105 (88.2%) patients
were successfully followed up in June 2004. Reasons for loss
to follow-up included an incorrect phone number, nobody
answered the phone and refusal. There were no significant
differences between the patients that were followed up and
those who were not followed up in sex, diagnoses and presence
of reactive symptoms. However, patients who were not
followed up appeared to be older than the patients who were
followed up.
Measurements
Structured questionnaires were designed to determine the
patients’ reactions to the treatment and it’s perceived efficacy.
Subjects gave their consent to participate in the study during
their first visit for Sanfujiu at the hospital. One week after each
of the three treatments and 1 year after completion, a telephone
interview was conducted with the patients by trained
interviewers. For patients under 12 years of age, questions
were answered by their primary caregivers. At 1 week after
treatment, the variables included patient background informa-
tion (age, sex, history of allergic diseases and medicine used
before treatment), reactive symptoms to treatment (blisters,
itching, pain, local heat, local redness, headache, insomnia,
runny nose, nasal congestion, sore throat, aches all over the
body, itching all over the body, constipation and diarrhea) and
perceived efficacy of treatment. At 1 year after treatment, the
variables included the number of allergic attacks, changes in
the use of medicine for allergic symptoms and perceived
efficacy. Perceived treatment efficacy was obtained by asking
the patient to rate the efficacy as very effective, somewhat
effective, no change (neither good nor bad) or worse than
before the treatment.
Data Analysis
Statistical analyses were carried out using the Statistical
Package for the Social Sciences, SPSS for Windows, Version
12.0 (SPSS Inc., Chicago, IL). Individual variables were
examined using the percentage, median, mean and standard
deviation. Chi-squared statistics were performed to examine
variations in the perceived treatment efficacy among different
subsets of patients. Student’s t-test was used to determine
mean differences in the number of reactive symptoms by
perceived treatment efficacy.
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Characteristics of the Subjects
The median age of the study subjects was 15 years (range,
1–78 years). About 57% of the study subjects were males. The
most-prevalent allergic diagnoses wereallergicrhinitis (61.0%),
asthma (37.1%) and allergiceczema(24.8%).Asfor the allergic
symptoms before the treatment, more than 75% had nasal
congestion and runny noses. More than 50% reported coughing,
itchy nose and eyes, and dark circles around the eyes. A high
proportion of patients reported having had reactive symptoms
1w e e ka f t e rt h eS a n f u j i ut r e a t m e n t .O v e r a l l , 80% of patients
reported having local redness or local heat after removal of the
drug paste at one or more of the three treatment times. Local
itching, runny nose, nasal congestion or local pain occurred in
more than 50% of the study subjects (Table 1).
Perceived Severity of Allergic Symptoms after
Treatment
The perceived severity of allergic symptoms during the
follow-up period is presented in the Table 2. The most-
prevalent symptoms were nasal congestion, runny nose, itchy
nose and itchy eyes, with more than 60% of patients reporting
such symptoms. More than 20% of patients reported that their
symptoms of runny nose, nasal congestion, itchy nose, itchy
eyes, itchy skin and dark circles around eyes were ‘severe’.
When the severity of the allergic symptoms was compared
with that before the treatment, 23.6–52.1% of patients reported
that their symptoms had lessened. Except for the dark circles
around the eyes, all other symptoms had a rate of improvement
of greater than 40% (Table 2).
Treatment Efficacy
At 1 week after treatment, six patients (5.7%) perceived
treatment as being ‘very effective’, and 42 (40.0%) reported it
as ‘somewhat effective’. At 1 year after the treatment, 24
patients (22.9%) perceived the treatment as being ‘very
effective’, and 38 (36.2%) reported it as ‘somewhat effective’.
In terms of the number of allergic attacks during the period, 46
(43.8%) subjects reported that the number of attacks had
decreased, while another 52 (49.5%) and 7 (6.7%) patients
reported no changes and increases in the number of attacks.
Aside from the 14 patients who did not use any drugs to treat
their allergies, 21 (23.1%) patients reported decreases in their
drug use for allergies, while 3 (3.3%) patients reported
increases in drug use (Table 1).
Factors Associated with Perceived Treatment Efficacy
To examine factors associated with perceived efficacy of
treatment, we divided the variable of perceived efficacy into
Figure 1. Descriptive figure of the Sanfujiu treatment.
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associated with perceived efficacy of treatment: 69.5% of
patients with an age of <19 years perceived the treatment as
being effective, while the corresponding figures were 48.1
and 42.1% for patients aged 19–40 and >40, respectively
(P ¼ 0.04). The cut-off point of 19 years of age was selected
because it is the usual age to determine whether the patient is a
pediatric patient. The cut-off point of 40 years was selected to
preserve enough sample size for the older age group (>40
years, n ¼ 19). Patients with a diagnosis of asthma were more
likely to report the treatment as being effective (71.4 versus
50.8%, P ¼ 0.035). The perceived efficacy of the Sanfujiu
treatment was not related to the patient’s sex or diagnosis of
allergic rhinitis or allergic eczema (Table 3). The mean
numbers of reactive symptoms immediately after each of the
three Sanfujiu treatment were 3.06 (SD ¼ 2.10), 3.21
(SD ¼ 2.28) and 3.12 (SD ¼ 1.84), respectively. There were
no significant differences in the mean number of reactive
symptoms for the first two treatments between patients who
perceived the treatment as effective and those who perceived
the treatment as ineffective. At the third treatment, patients
who perceived the treatment as effective had a higher number
of reactive symptoms than patients who perceived the
treatment as ineffective (with a mean number of reactive
symptoms of 3.45 versus 2.65, P ¼ 0.03; Table 4).
Discussion
The results of this study demonstrated that 45.7 and 59.1% of
patients perceived the Sanfujiu treatment as being effective at
1 week and 1 year after the treatment. The figure at 1 year was
higher than that at 1 week after treatment. Previously,
researchers in China showed that Sanfujiu had effectiveness
rates of greater than 80% in treating rhinitis, chronic bronchitis
and asthma (9–14). However, those studies generally lacked
common criteria for determining treatment efficacy. Thus, a
comparison of effectiveness rates cannot be made. In our
study, we found that over 40% of patients reported a decrease
in the severity of each of the included allergic symptoms,
except for dark circles around the eyes. In addition, 43.8 and
23.1% of patients reported decreases in the number of allergic
attacks and decreases in the amount of medicine used for their
allergic symptoms. Altogether, these results demonstrated that
Sanfujiu treatment was moderately effective in treating
patients with allergies.
Here, we found that patients who were younger (<19 years)
were more likely to report the treatment as being effective.
This finding is consistent with the results of previous studies in
that the treatment effects were better for children than adults
(12). Further, we found that patients with the diagnosis of
asthma were more likely to report an effective outcome.
Studies in China have shown the effects of Sanfujiu in treating
rhinitis, chronic bronchitis and asthma (9–14). However, they
did not compare the perceived efficacy across diagnoses. In
our study, we found effectiveness rates of 71.4% for asthma,
61.3% for rhinitis and 54.8% for eczema. Since these allergic
Table 1. Patient characteristics and treatment efficacy (N ¼ 105)
n Percent
Age (years)
<19 59 56.2
19–40 27 25.7
>40 19 18.1
Sex
Male 60 57.1
Female 45 42.9
History of allergies
Allergic rhinitis 64 61
Asthma 39 37.1
Allergic eczema 26 24.8
Others 18 17.1
Presence of reactive symptoms immediately after the treatment
Local redness 85 81
Local heat 83 79
Local itching 65 61.9
Runny nose 61 58.1
Nasal congestion 58 55.2
Local pain 53 50.5
Dry mouth or thirst 29 27.6
Insomnia 23 21.9
Sore throat 18 17.1
Headache 18 17.1
Itching all over the body 18 17.1
Constipation 13 12.4
Diarrhea 13 12.4
Aches all over the body 12 11.4
Local blisters 12 11.4
Others 8 7.6
Perceived efficacy immediately after the treatment
Very effective 6 5.7
Somewhat effective 42 40
Neither good nor bad 53 50.5
Allergic symptoms worsened 4 3.8
Perceived efficacy 1 year after the treatment
Very effective 24 22.9
Somewhat effective 38 36.2
Neither good nor bad 41 39
Allergic symptoms worsened 2 1.9
Number of allergic attacks during the past year
Decrease 46 43.8
No changes 52 49.5
Increase 7 6.7
Use of medicine to treat allergies during the past year*
Decrease 21 23.1
No changes 67 73.6
Increase 3 3.3
*Fourteen patients who did not use any drugs to treat their allergies
were excluded.
244 Treatment efficacy of sanfujiusymptoms may be comorbid, further studies are needed to
compare the relative efficacies of the Sanfujiu treatment for
different combinations of symptoms and diagnoses. We
acknowledge that our study and previous studies relied on
patients’ reports of having been diagnosed with an allergic
disease. Future studies should use standardized diagnostic
procedures in order to address this problem.
We previously documented the reactive symptoms to
Sanfujiu treatment (7). Although a wide range of reactive
symptoms was noted, the reactive symptoms were usually mild
and were relieved by removing the herbal paste. In this study,
patients who perceived the treatment as being effective had
higher numbers of reactive symptoms after the third Sanfujiu
treatment. In a previous study, researchers reported that among
patients with asthma, patients with topical reactions imme-
diately after the treatment exhibited higher effectiveness rates
(15). Since according to TCM theory the Sanfujiu treatment
strengthens the qi by means of the herbal paste, the acupoints
and the seasonal qi in the environment, it may be that these
reactions are evidence of expelling the illness via the
acupoints. Further study is needed to validate this speculation.
The application of Chinese herbal medicine on acupoints for
treating allergic diseases is an area that has not been studied
much. According to the theory of Chinese medicine, allergic
diseases are classified as ‘winter diseases’ since allergic
symptoms usually become worse during the winter. The winter
diseases are best treated in the summer according to the theory
(16). The Sanfujiu treatment applies the principles of the
‘winter disease being treated in the summer’. The elements
involved in the Sanfujiu treatment include yang qi associated
with the peak summer days, qi inside the body and medicinal
effects through the acupoints. In TCM, humans and their
environment are seen as one. According to the lunar calendar,
the dog days are the days with the highest temperatures and
highest amount of yang qi. During these days, the surface and
blood vessels of the human body are ecstatic; therefore, it is
easier for the herbs to penetrate the acupoints and enhance
the lung qi through the environmental yang qi. We speculate
that Sanfujiu may strengthen qi and the immune system of the
body, and increase the threshold to induce an allergic attack.
However, the proposed mechanisms are based on theories
rather than empirical studies. In addition, five herbs were used
Table 2. Perceived severity of allergic symptoms after completion of Sanfujiu treatment (N ¼ 105)
Symptoms n (%) with each symptom Severity of symptoms Symptom severity compared with before the treatment
Mild % Severe % Improved % No different % Worsened %
Wheezing 39 (37.1) 22.9 14.3 48.7 41.0 10.3
Runny nose 82 (78.1) 51.4 26.7 47.6 48.8 3.7
Nasal congestion 83 (79.0) 54.3 24.7 47.0 49.4 3.6
Cough 48 (45.7) 31.4 14.3 52.1 41.7 6.3
Nose itching 76 (72.4) 47.6 24.8 42.1 53.9 3.9
Eye itching 66 (62.9) 40.0 22.8 40.9 53.0 6.1
Dark circles around eyes 55 (52.4) 32.4 20.0 23.6 74.5 1.8
Skin itching 55 (52.4) 30.5 21.9 40.0 52.7 7.3
Others 11 (10.5) 5.7 4.8 45.5 45.5 9.1
Table 3. Perceived efficacy of Sanfujiu in alleviating allergic symptoms
1 year after treatment based on patient characteristics
Percent improved P
Age (years)
<19 69.5 0.04
19–40 48.1
>40 42.1
Sex
Male 64.4 0.18
Female 51.2
Allergic rhinitis
Yes 61.3 0.45
No 53.3
Asthma
Yes 71.4 0.035
No 50.8
Allergic eczema
Yes 54.8 0.57
No 60.8
Other allergies
Yes 61.1 0.85
No 58.6
P-value from c
2 statistics.
Table 4. Mean number of reactive symptoms (SD) after each of the three
treatments by perceived efficacy of Sanfujiu in alleviating allergic
symptoms 1 year after treatment
Effective Ineffective P
Mean number of reactive symptoms
after the first treatment
3.16 (2.19) 2.91 (1.99) 0.55
Mean number of reactive symptoms
after the second treatment
3.50 (2.38) 2.79 (2.09) 0.12
Mean number of reactive symptoms
after the third treatment
3.45 (1.75) 2.65 (1.89) 0.03
P-value from the Student’s t-test.
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cold, relieve pain, and promote circulation of blood and qi in
TCM. However, the active constituents of these herbs and their
effects are not clear. Another problem is whether the Sanfujiu
treatment could be given on days besides the dog days. A study
showed that treating patients with asthma during the three dog
days had similar effects to treating patients a few days apart
from the dog days. However, the effects disappeared when the
patients were treated in the autumn (17). More rigorous studies
are needed to examine the mechanisms of this treatment.
Conclusions
The results demonstrated that the Sanfujiu treatment was
moderately effective, as perceived by patients, in treating their
allergic symptoms. The presence of reactive symptoms
immediately after treatment was associated with a perceived
efficacy. Sanfujiu is appealing since it is non-invasive, reactive
symptoms are minor, and the course is relatively short and
easy. This study was limited by the lack of a control group,
thus the possibility of placebo-like effectiveness cannot be
ruled out. Also the subjects had some knowledge about
Sanfujiu prior to receiving treatment, which may influence
their perceived effectiveness. In order to address this concern,
we added information on the use of medicine and the number
of allergic attacks in addition to perceived efficacy. Our results
appeared to be consistent in supporting the efficacy of the
Sanfujiu. Randomized controlled trails are still needed to
determine the actual efficacy.
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